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Intracellular pH (pHi) was measured in HL60 and U937 cells before and after differentiation into monocyte-macrophage 
like cells. 120Tetradecanoyl phorbol-13-acetate (PMA), butyrate, interferon, retinoic acid and 1,25-dihydroxyvitamin 
D3 all increased pHi. The increases elicited were rapid with PMA, much slower with retinoic acid and interferon and 
still slower with 1,25_dihydroxyvitamin D3. Increases in pHi are due to an activation of the Na+/H’ exchange system. 
High pHi values are unlikely to serve as an early intracellular signal for initiating monocytic differentiation. 
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1. INTRODUCTION 
Maintenance of a defined pHi value seems to be 
important for a number of cellular functions. pHi 
is controlled in eukaryotic cells by membrane ion 
transporting systems, the most important being 
that of Na+/H+ exchange and the different bicar- 
bonate transporting systems [l-3]. The Na+/H+ 
exchange system is a target for a large variety of 
agents, including hormones and growth factors 
[3-51. We previously showed that in the human 
myeloid cell lines HL60 and U937, retinoic acid ac- 
tivates about 2-fold the Na+/H+ exchange system, 
and produces a cellular alkalinization [6,7]. 
Retinoic acid has no action on the activity of a 
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second pHi regulating mechanism, the 
Na+-dependent HCO:/Cl- exchange system [6,7]. 
Retinoic acid induces HL60 and U937 cells to dif- 
ferentiate along the granulocytic and monocytic 
differentiation pathways respectively [&lo]. In 
this paper we investigate the action of other agents 
that promote the monocytic differentiation in 
HL60 and U937 cells. These are phorbol esters 
[11,12], rIFN [13], butyrate [14] and 1,25-(OH)zD3 
[15,16]. 
2. MATERIALS AND METHODS 
[‘4C]Benzoic acid (19.3 mCi/mmol) was from New England 
Nuclear. 2’ ,7’-Biscarboxyethyl-5(6)-carboxyfluoresceinace- 
toxymethylester was purchased from Calbiochem. RPM1 1640 
culture.medium was from Gibco. Fetal bovine serum was from 
Boehringer. Nigericin and PMA were from Sigma. EIPA was 
synthesized as described [17]. 1,25-(OH)zDs and recombinant 
human y interferon (RU 42369) were from Roussel Uclaf. 
HL60 cells and U937 cells were grown in RPM1 1640 medium 
supplemented with 20% (HL60 cells) or 15% (U937 cells) heat 
inactivated fetal bovine serum, 2 mM glutamine, 100 W/ml 
penicillin and 100 gg/ml streptomycin at 37°C in a humidified 
atmosphere containing 5% COZ. Cells were seeded twice weekly 
at 3 x lo5 cells/ml. 
pHi values were determined from the distribution of 
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[‘?]benzoic acid or from the fluorescence of 2’,7’-biscarboxy- 
ethyl-5(6)-carboxyfluorescein as described [6]. The two techni- 
ques gave identical values of the pHi. In all cases, measure- 
ments were performed after equilibration of the cells for 30 min 
in a bicarbonate free Hepes buffered RPM1 1640 medium. 
Calibration was achieved using the nigericin/KCl method. 
For immunofluorescent detection of HLA-DR, 10s HL60 
cells, incubated in RPM1 1640 medium supplemented with 2% 
fetal bovine serum were stained with OKla-1 (Ortho Diagnostic 
System) for 1 h at 4”C, washed three times and incubated with 
goat anti-mouse IgG fluorescein isothiocyanate conjugate for 
an additional hour. Cells were then washed three times at 4°C 
and analyzed on a fluorescence activated cell sorter 
(Ortho-SOH) [18]. FACS analyses were performed in the 
‘Laboratoire de Cytometrie en Flux’, Hopital Saint Louis, 
Paris. Radioimmunoassay of HLA-DR was carried out as 
described [19] using Dl-12 anti-human HLA-DR antibodies. 
3. RESULTS AND DISCUSSION 
Undifferentiated HL60 cells have a mean pHi of 
7.00 + 0.03 [6]. After 4 days of exposure to 
0.5 mM butyrate or to 0.1 PM 1,25-(OH)zDs, pHi 
increased to 7.16 f 0.02 (n = 5) and to 7.20 + 0.02 
(n = 5) respectively. After 5 days of treatment with 
100 IU/ml rIFN, pHi increased to 7.13 + 0.01 (n = 
5). PMA induced HL60 and U937 cells to attach to 
plastic surfaces [12]. The pHi of adherent cells, 
measured after 2 days of exposure to 5 nM PMA 
was 7.23 + 0.02 (n = 6). Similarly exposure of 
U937 cells for 4 days to 1 PM retinoic acid induced 
a cellular alkalinization from 7.03 f 0.02 to 7.23 
+ 0.03 [7]. After treatment with these agents, 
blocking Na+/H+ exchange activity with EIPA 
[6,7,20,21] decreased the steady state pHi value to 
6.95 t- 0.02 irrespective of the agent used. These 
experiments indicated (i) that all inducers of the 
pH ““,, , ypyl i;:,“,, 0.1 
EIPA 10 ,,Y EIPA 10 pll 
* kM 
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Fig.1. Effect of PMA on the pHi of HL60 and U937 cells. 
2’ ,7 ’ -Biscarboxyethyl-5(6)-carboxyfluorescein loaded HL60 
cells (left) and U937 cells (right) were suspended in 140 mM 
Na+ Earle’s salt solution. When indicated, PMA (0.1 PM) or 
EIPA (1OpM) was added to the cells. 
monocytic-macrophage differentiation pathway 
produced an increase in pHi and (ii) that this in- 
crease resulted from an increased activity of the 
Na+/H+ exchange system. The increase in pHi was 
lowest with rIFN (0.14 pH unit) and highest with 
retinoic acid (in U937 cells) or PMA (0.23 pH 
unit). It seems therefore that pHi changes are 
linked in some way to the acquisition of monocytic 
properties. An increase to a pHi value of 
7.14-7.23 characterizes the monocytic lineage. A 
larger increase to pHi values of 7.30-7.37 has 
previously been shown to occur during the 
granulocytic differentiation of HL60 cells [6]. 
We next compared the time courses of pHi 
changes after treatment of the cells with different 
inducers. Addition of PMA (0.1 ,uM) to HL60 cells 
(fig. 1A) or to U937 cells (fig. 1B) produced a rapid 
and monophasic increase in the pHi of 0.3 pH 
units which was not observed in the presence of 
EIPA (fig.1). The rapid effect of PMA on pHi is 
typical of an action mediated by protein kinase C 
[22,23]. The dose-response curves for PMA action 
on the pHi of HL60 and U937 cells are presented 
in fig.2. EDso values were observed at 5 nM for the 
two cell types, The EDso value for PMA action on 
the cell ability to adhere to plastic surfaces was 
0.5 nM in the two cell lines (fig.2), i.e. a value 10 
times lower than the EDso value for PMA action 
on pHi. As a consequence, PMA at a concentra- 
100 
t I 7.9 
Fig.2. Dose-response curves for PMA action on the pHi and the 
differentiation of leukemic cells. Cells used were HL60 cells 
(0,o) and U937 cells (A , n ). pHi was measured 30 min after 
the addition of PMA to the cells using [‘4C]benzoic acid 
(0, A). Each point is the mean of 5 to 6 determinations. 
Differentiation (m .o) was measured as the percent of cells 
adhering to plastic surfaces after 2 days of exposure to PMA. 
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tion of 0.1 nM, induced the adhesion of 17% to 
38% of the cells without detectable increase in 
pHi. This suggests that an increase in pHi may not 
be necessary for inducing macrophage differentia- 
tion in response to PMA. 
rIFN produced no change in pHi during the first 
hours of its exposure. Then pHi increased steadily 
to reach a maximum after 4 to 5 days (fig.3). The 
time course of pHi change induced by rIFN closely 
paralleled the time course of appearance of HLA- 
DR (fig.3) and of receptor sites for interleukin 2 
(not shown). A similar time course of pHi change 
has been reported for U937 cells that have been 
treated with retinoic acid [7]. The inset of fig.3 
shows the dose response curves for rIFN action on 
the pHi and on HLA-DR expression. Half max- 
[rlFN) (IWml) 
Fig.3. Effect of rlFN on the pHi of HL60 cells. Time course of 
pHi changes and of appearance of HLA-DR after treatment of 
HL60 cells with 100 lU/ml of rlFN. pHi (0) was measured 
using 2’ ,7 ’ -biscarboxyethyl-5(6)-carboxyfluorescein. Bars 
indicate the mean k SD from 3 to 5 determinations. HLA-DR 
(0) was assayed by flow cytometric analysis of cells labelled 
with fluorescent anti-HLA-DR antibodies. (Inset) Dose 
response curve for rlFN action on the pHi (0) and HLA-DR 
(0). Experiments were performed after 3 days of treatment 
with rlFN. 100% on the ordinate scale corresponds to 0.13 pH 
unit. Each point represents the mean from 3 determinations. 
HLA-DR was determined by radioimmunoassay. 
imum effect was observed at 10 II-J/ml for both 
pHi changes and HLA-DR expression. 
A third situation was found for 1,25-(OH)zD3. 
After treatment of HL60 cells with 0.1 FM 
1,25-(OH)zD3, pHi remained stable for 2 days. It 
increased to 7.20 f 0.08 (n = 6) at day 3 and then 
stabilized. Thus the different agents that induce 
myeloid cells to acquire monocytic properties 
modify pHi with very different time courses. 
Variations in pHi are almost immediate with 
PMA, much slower with retinoic acid [7] and rIFN 
and still slower with 1,25-(OH)zD3. It is not known 
whether the different time courses of pHi change 
correspond to distinct activation pathways for the 
Na+/H+ exchange system. Finally we confirmed 
the observations by Carlson et al. [24] showing 
that N-5 disubstituted derivatives of amiloride 
such as EIPA, at concentrations ufficient to block 
most of the activity of the Na+/H+ exchange 
system, did not prevent the appearance of the dif- 
ferentiated phenotype. 
Taken together the results suggest that an in- 
crease in pHi is unlikely to be important as an early 
intracellular signal for initiating monocytic dif- 
ferentiation. High pHi values probably arise as a 
consequence of the differentiation process. They 
might be important for late stages of differentia- 
tion or for the expression of functional 
macrophage properties such as superoxide genera- 
tion [25,26]. 
Acknowledgements: This work was supported by grants from 
the CNRS, the INSERM, the ‘Fondation pour la Recherche 
Medicale’ and the ‘Fondation contre la Leucemie’. A.L. is reci- 
pient of a fellowship from the ‘Association pour la Recherche 
contre le Cancer’. 
REFERENCES 
[l] Roos, A. and Boron, W. (1981) Physiol. Rev. 61, 
296-434. 
[2] Frelin, C., Vigne, P., Barbry, P. and Lazdunski, M. 
(1987) Kidney lnt. 32, 785-793. 
[3] Frelin, C., Vigne, P., Ladoux, A. and Lazdunski, M. 
(1988) Eur. .I. Biochem., in press. 
[4] Moolenaar, W.H. (1986) Annu. Rev. Physiol. 48, 
363-376. 
[5] Grinstein, S. and Rothstein, A. (1986) J. Membr. Biol. 
90, l-12. 
[6] Ladoux, A., Cragoe, E.J. jr, Geny, B., Abita, J.P. and 
Frelin, C. (1987) J. Biol. Chem. 262, 811-816. 
355 
Volume 234, number 2 FEBS LETTERS July 1988 
[7] Ladoux, A., Miglierina, R., Krawice, I., Cragoe, E.J. jr, [17] Cragoe, E.J. jr, Woltersdorf, O.W., Bicking, J.B., 
Abita, J.P. and Frelin, C. (1988) Eur. J. Biochem., in Kwong, S.K. and Jones, J.H. (1967) J. Med. Chem. 10, 
press. 66-75. 
[8] Harris, P. and Ralph, P. (1985) J. Leuk. Biol. 37, 
407-412. 
[9] Collins, S.J. (1987) Blood 70, 1233-1244. 
[lo] Sundstrom, C. and Nilsson, K. (1976) Int. J. Cancer 17, 
565-577. 
[18] Carrel, S., Tosi, R., Gross, N., Tanigaki, N., 
Carmagnola, A.L. and Accola, R.S. (1981) Mol. 
Immunol. 18, 403-411. 
[ll] Huberman, E. and Callaham, M. (1979) Proc. Natl. 
Acad. Sci. USA 76, 1293-1297. 
[12] Rovera, G., Santoni, D. and Damsky, C. (1979) Proc. 
Natl. Acad. Sci. USA 76, 2779-2783. 
[13] Ball, E., Guyre, P., Shen, L., Glynn, J., Maliszewski, C., 
Baker, P. and Fanger, M. (1984) J. Clin. Invest. 73, 
1072-1077. 
[19] Rambaldi, A., Young, D.C., Herrmann, F., Cannistra, 
S.A. and Griffin, J.D. (1987) Eur. J. Immunol. 17, 
153-156. 
[14] Koeffler, H.P. (1983) Blood 62, 709-721. 
[15] Tanaka, H., Abe, E., Miyaura, C., Shilina, Y. and Suda, 
T. (1983) Biochem. Biophys. Res. Commun. 117, 86-92. 
[16] Tanaka, H., Abe, E., Miyaura, C., Kuribayashi, T., 
Konno, K., Nishii, Y. and Suda, T. (1982) Biochem. J. 
204. 713-719. 
[20] Vigne, P., Frelin, C., Cragoe, E.J. and Lazdunski, M. 
(1983) Biochem. Biophys. Res. Commun. 116, 86-90. 
[21] Vigne, P., Frelin, C., Cragoe, E.J. and Lazdunski, M. 
(1984) Mol. Pharmacol. 25, 131-136. 
[22] Grinstein, S., Cohen, S., Goetz, J.D., Rothstein, A. and 
Gelfand, E.W. (1984) Proc. Natl. Acad. Sci. USA 82, 
1429-1433. 
[23] Green, R.D., Frelin, C., Vigne, P. and Lazdunski, M. 
(1986) FEBS Lett. 196, 163-166. 
[24] Carlson, J., Dorey, S., Cragoe, E.J. jr and Koeffler, H.P. 
(1984) J. Natl. Cancer Inst. 72, 13-18. 
[25] Simchowitz, L. (1985) J. Clin. Invest. 76, 1079-1089. 
[26] Weisman, S.J., Punzo, A., Ford, C. and Sha’afi, R.I. 
(1987) J. Leuk. Biol. 41, 25-32. 
356 
